Last week, drugmaker Eli Lilly announced results from a late-stage diabetes trial showing that its daily GLP-1 pill orforglipron significantly reduced A1C (a measure of blood sugar) and body weight compared with placebo (a sham pill)
Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM, Abalos FH, Manghi FCP, Zaidman CJ, Vico ML, Aizenberg D, Costanzo PR, Serra LP,
Hold the liquid under your tongue for at least 2 minutes
This four-day window is shorter than semaglutide at five days, reflecting tirzepatide shorter half-life
If you have a BMI of 22 or higher, you may be an eligible candidate for the GLP-1 Microdose Protocol
GLP-1 is a natural hormone that helps control appetite and boost weight loss, while Ozempic is an effective medication that mimics GLP-1s effects for lasting results